Published in J Intern Med on July 01, 2007
Human resistin: found in translation from mouse to man. Trends Endocrinol Metab (2011) 1.51
Association of variants in RETN with plasma resistin levels and diabetes-related traits in the Framingham Offspring Study. Diabetes (2008) 1.04
Resistin in rodents and humans. Diabetes Metab J (2013) 1.03
Resistin gene variation is associated with systemic inflammation but not plasma adipokine levels, metabolic syndrome or coronary atherosclerosis in nondiabetic Caucasians. Clin Endocrinol (Oxf) (2008) 0.93
Association of resistin polymorphism, its serum levels and prevalence of stroke in Japanese type 2 diabetic patients. J Diabetes Investig (2010) 0.90
Influence of Obesity and Related Metabolic Alterations on Colorectal Cancer Risk. Curr Nutr Rep (2012) 0.88
Association between OLR1 K167N SNP and intima media thickness of the common carotid artery in the general population. PLoS One (2012) 0.83
Interaction of Polymorphisms of Resistin Gene Promoter -420C/G, Glutathione Peroxidase -1 Gene Pro198Leu and Cigarette Smoking in Nonalcoholic Fatty Liver Disease. Chin Med J (Engl) (2015) 0.77
Associations of Resistin Levels with Resistin Gene Polymorphism and Metabolic Syndrome in Thais. J Med Biochem (2015) 0.77
Relevance Study on Cerebral Infarction and Resistin Gene Polymorphism in Chinese Han Population. Aging Dis (2016) 0.75
Association of +62 G>A Polymorphism in the Resistin Gene with Type 2 Diabetes Mellitus among Thais: Case-Control Study. J Clin Diagn Res (2017) 0.75
Absence of evidence for an association between resistin gene variants and insulin resistance in an Asian population with low and high blood pressure. Diabetes Res Clin Pract (2008) 0.75
IDOL N342S Variant, Atherosclerosis Progression and Cardiovascular Disorders in the Italian General Population. PLoS One (2015) 0.75
Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet (1999) 4.04
Moderate alcohol use and health: a consensus document. Nutr Metab Cardiovasc Dis (2013) 2.77
Calcitriol and calcium carbonate therapy in early chronic renal failure. Nephrol Dial Transplant (1994) 2.03
Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. Northern Italian Cooperative Study Group. Lancet (1991) 1.82
Strontium absorption and excretion in normocalciuric subjects: relation to calcium metabolism. Clin Chem (1998) 1.76
Pharmacology of competitive inhibitors of HMG-CoA reductase. Pharmacol Res (1995) 1.62
Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study. Int J Clin Pract (2009) 1.61
A novel component of the metabolic syndrome: the oxidative stress. Nutr Metab Cardiovasc Dis (2009) 1.49
Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study. Am J Kidney Dis (2000) 1.43
Role of vitamin E-coated membrane in reducing advanced glycation end products in hemodialysis patients: a pilot study. Blood Purif (2006) 1.40
Carotid atherosclerosis in renal transplant recipients: relationships with cardiovascular risk factors and plasma lipoproteins. Transplantation (1999) 1.38
Recombinant human erythropoietin (rhEPO) treatment potentiates growth hormone (GH) response to growth hormone releasing hormone (GHRH) stimulation in hemodialysis patients. Clin Nephrol (1993) 1.38
Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med (1990) 1.32
Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur J Endocrinol (2007) 1.27
Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy. Curr Med Res Opin (2007) 1.19
Bilateral symmetric retinal detachment and multiple retinal pigment epithelial detachments during haemodialysis. Nephrol Dial Transplant (1998) 1.09
Proteinuria and blood pressure as causal components of progression to end-stage renal failure. Northern Italian Cooperative Study Group. Nephrol Dial Transplant (1996) 1.07
Estrogen up-regulates apolipoprotein E (ApoE) gene expression by increasing ApoE mRNA in the translating pool via the estrogen receptor alpha-mediated pathway. J Biol Chem (1997) 1.07
Barriers to cardiovascular disease risk scoring and primary prevention in Europe. QJM (2010) 1.06
In vivo assimilation of low density lipoproteins by a fibrosarcoma tumour line in mice. Cancer Lett (1984) 1.04
Proprotein convertase subtilisin/kexin type 9 (PCSK9): from structure-function relation to therapeutic inhibition. Nutr Metab Cardiovasc Dis (2011) 1.03
Autolysis of human erythrocyte calpain produces two active enzyme forms with different cell localization. FEBS Lett (1996) 1.01
High density lipoprotein cholesterol levels are an independent predictor of the progression of chronic kidney disease. J Intern Med (2013) 1.00
Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia. Arterioscler Thromb Vasc Biol (1995) 0.99
MicroRNA 143-145 deficiency impairs vascular function. Int J Immunopathol Pharmacol (2012) 0.98
Assimilation of LDL by experimental tumours in mice. Biochim Biophys Acta (1989) 0.97
Activation of lipoprotein lipase by synthetic fragments of apolipoprotein C-II. Ann N Y Acad Sci (1980) 0.97
Experimental hypothyroidism modulates the expression of the low density lipoprotein receptor by the liver. Atherosclerosis (1986) 0.96
Increased thromboxane biosynthesis in type IIa hypercholesterolemia. Circulation (1992) 0.96
Changes in intracellular localization of calpastatin during calpain activation. Biochem J (1999) 0.95
Effect of the Toll-like receptor 4 (TLR-4) variants on intima-media thickness and monocyte-derived macrophage response to LPS. J Intern Med (2005) 0.94
Liver X receptor and retinoic X receptor agonists modulate the expression of genes involved in lipid metabolism in human endothelial cells. Int J Mol Med (2005) 0.94
Familial defective apo B-100, characterization of an Italian family. Eur J Clin Invest (1991) 0.92
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus. J Thromb Haemost (2010) 0.92
Plasma adiponectin levels in chronic kidney disease patients: relation with molecular inflammatory profile and metabolic status. Nutr Metab Cardiovasc Dis (2009) 0.92
Ability of the LDL receptor from several animal species to recognize the human apo B binding domain: studies with LDL from familial defective apo B-100. Atherosclerosis (1992) 0.92
Bile lipid composition and haemostatic variables in a case of high density lipoprotein deficiency (Tangier disease). Eur J Clin Invest (1984) 0.91
Conversion of recent-onset atrial fibrillation to sinus rhythm: effects of different drug protocols. Pacing Clin Electrophysiol (1998) 0.91
Gene expression and intracellular pathways involved in endothelial dysfunction induced by VLDL and oxidised VLDL. Cardiovasc Res (2003) 0.90
Plasma lipids, lipoproteins and apoproteins in a case of apo C-II deficiency. Clin Chim Acta (1983) 0.88
Known mutations of apoB account for only a small minority of hypobetalipoproteinemia. J Lipid Res (1999) 0.88
Different patterns characterize Omega 6 and Omega 3 long chain polyunsaturated fatty acid levels in blood from Italian infants, children, adults and elderly. Prostaglandins Leukot Essent Fatty Acids (2013) 0.88
Dietary cholic acid lowers plasma levels of mouse and human apolipoprotein A-I primarily via a transcriptional mechanism. Eur J Biochem (2000) 0.88
Triglyceride-rich lipoproteins from hypertriglyceridemic subjects induce a pro-inflammatory response in the endothelium: Molecular mechanisms and gene expression studies. J Mol Cell Cardiol (2006) 0.87
Creatinine clearance and signs of end-organ damage in primary hypertension. J Hum Hypertens (2004) 0.87
Subfractionation of human very low density lipoproteins by heparin-Sepharose affinity chromatography. J Lipid Res (1983) 0.87
HDL3 induces cyclooxygenase-2 expression and prostacyclin release in human endothelial cells via a p38 MAPK/CRE-dependent pathway: effects on COX-2/PGI-synthase coupling. Arterioscler Thromb Vasc Biol (2004) 0.87
Total orthotopic small bowel transplantation with cyclosporine: morphology and function in a swine model. Transplant Proc (1992) 0.87
Acyl-CoA-binding protein is a potent m-calpain activator. J Biol Chem (2000) 0.87
Hepatitis G virus infection in hemodialysis patients. Kidney Int (1997) 0.87
Study of calcium metabolism in idiopathic hypercalciuria by strontium oral load test. Clin Chem (1999) 0.87
Telomere shortening over 6 years is associated with increased subclinical carotid vascular damage and worse cardiovascular prognosis in the general population. J Intern Med (2014) 0.86
Oxidized-LDL induce the expression of heat shock protein 70 in human endothelial cells. Biochem Biophys Res Commun (1994) 0.86
Unique epitope of apolipoprotein A-I expressed in pre-beta-1 high-density lipoprotein and its role in the catalyzed efflux of cellular cholesterol. Biochemistry (1994) 0.86
Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiency. Atherosclerosis (2009) 0.86
Oxidized LDL increase free cholesterol and fail to stimulate cholesterol esterification in murine macrophages. Biochem Biophys Res Commun (1990) 0.85
Properties of calpastatin forms in rat brain. FEBS Lett (1998) 0.85
Microalbuminuria is an integrated marker of subclinical organ damage in primary hypertension. J Hum Hypertens (2002) 0.85
Simvastatin modulates the heat shock response and cytotoxicity mediated by oxidized LDL in cultured human endothelial smooth muscle cells. Biochem Biophys Res Commun (1997) 0.85
Vaginal colonization with group B Streptococcus (Streptococcus agalactiae) and peritonitis in a woman on CAPD. Nephrol Dial Transplant (1999) 0.85
Oxidized LDL induce hsp70 expression in human smooth muscle cells. FEBS Lett (1995) 0.84
Differential degradation of calpastatin by mu- and m-calpain in Ca(2+)-enriched human neuroblastoma LAN-5 cells. FEBS Lett (2000) 0.84
Stress proteins and atherosclerosis. Atherosclerosis (1996) 0.83
Bone mass status in different degrees of chronic renal failure. Bone (1992) 0.83
Suppression of 3-hydroxy-3-methylglutaryl-CoA reductase by low density lipoproteins produced in vitro by lipoprotein lipase action on nonsuppressive very low density lipoproteins. J Biol Chem (1979) 0.83
Effects of a phytosterol-enriched dairy product on lipids, sterols and 8-isoprostane in hypercholesterolemic patients: a multicenter Italian study. Nutr Metab Cardiovasc Dis (2008) 0.83
Effects of calcium antagonists on lipids and atherosclerosis. Am J Cardiol (1989) 0.83
Molecular characterization of adult-colonizing Streptococcus agalactiae from an area-based surveillance study in Romania. Eur J Clin Microbiol Infect Dis (2012) 0.83
Comparative in vitro study of the pro-apolipoprotein A-I to apolipoprotein A-I converting activity between normal and Tangier plasma. J Clin Invest (1984) 0.83
Defective catabolism of oxidized LDL by J774 murine macrophages. J Lipid Res (1992) 0.83
Modulation of rat brain calpastatin efficiency by post-translational modifications. FEBS Lett (1997) 0.82
Abnormal suppression of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by hypertriglyceridemic very low density lipoprotein subclasses. Lipids (1980) 0.82
Enhanced platelet release reaction in insulin-dependent and insulin-independent diabetic patients. Haemostasis (1982) 0.82
Lipid lowering activity of drugs affecting cholesterol absorption. Nutr Metab Cardiovasc Dis (2004) 0.82
Lipolysis of ApoC-II deficient very low density lipoproteins: enhancement of lipoprotein lipase action by synthetic fragments of apoC-II. Biochem Biophys Res Commun (1979) 0.82